Published in Women's Health Weekly, June 26th, 2003
"The activity seen in the epothilone phase II studies is encouraging and we plan to now move forward with the development of this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.